ORKA - Oruka Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Oruka Therapeutics, Inc. Common Stock
IPO Date: September 3, 2024
Sector: Healthcare
Industry: Biotech
Market Cap: $6.29B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.29 | 4.11%
Avg Daily Range (30 D): $2.82 | 2.81%
Avg Daily Range (90 D): $2.63 | 3.12%
Institutional Daily Volume
Avg Daily Volume: .47M
Avg Daily Volume (30 D): .6M
Avg Daily Volume (90 D): .91M
Trade Size
Avg Trade Size (Sh.): 61
Avg Trade Size (Sh.) (30 D): 43
Avg Trade Size (Sh.) (90 D): 56
Institutional Trades
Total Institutional Trades: 903
Avg Institutional Trade: $3.92M
Avg Institutional Trade (30 D): $7.5M
Avg Institutional Trade (90 D): $6.05M
Avg Institutional Trade Volume: .07M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $7.64M
Avg Closing Trade (30 D): $16.36M
Avg Closing Trade (90 D): $14.35M
Avg Closing Volume: 132.34K
 
News
Aug 24, 2026 @ 8:01 PM
Oruka Therapeutics Appoints Todd Edwards as Chief ...
Source: Not Specified
Jun 27, 2026 @ 7:28 PM
Oruka Stock Is Now Up Nearly 700%. Here's What a $...
Source: Jonathan Ponciano
Jun 24, 2026 @ 9:24 PM
Oruka Therapeutics' Head of Finance Sold Over 10,0...
Source: Robert Izquierdo
May 31, 2026 @ 2:21 PM
An Oruka Therapeutics (ORKA) Insider Sold 105,000 ...
Source: Cory Renauer
May 11, 2026 @ 9:15 PM
A Tiny Biotech Just Beat AbbVie's $17 Billion Drug...
Source: Prosper Junior Bakiny
Financials
  TTM Q1 2026 Q4 2025
Basic EPS
Diluted EPS
Revenue $M $M $M
Gross Profit
Net Income / Loss $-41.21M $-31.82M $-29.58M
Operating Income / Loss $-50.11M $-36.43M $-34.43M
Cost of Revenue
Net Cash Flow $218.95M $2.59M $-44.32M
PE Ratio